Loading lessons…
Loading lessons…
Curated lessons across 8 learning paths — from first concepts to trial summaries and practical protocols. Pick your level, follow the curriculum, and build real understanding.
Where are you starting?
Choose a learning path below or search the library. Progress saves in your browser.
Pick a track — progress rings update as you complete lessons.
19 lessons
8mGLP-1s can drive impressive weight loss, but the real win is losing fat without giving up strength. This guide shows how to protect lean mass while appetite is down.
9mMOTS-C sits at the intersection of mitochondrial signaling, glucose control, and recovery biology. Here is what the current research can actually support.
9mYou don't need to have diabetes to benefit from GLP-1 therapy. A comprehensive 2026 systematic review confirms what the peptide community has known for years — and the results are striking.
8mYou've been on Retatrutide for 4-6 weeks and the scale hasn't budged. Before you give up or double your dose, here are the real reasons Reta might not be 'working' — and what to actually do about it.
9mAlready on Reta and ready to add compounds? Here's how to stack Tesamorelin and MOTS-C with Retatrutide for maximum fat loss and recomp.
9mRetatrutide is one of the most powerful GLP-1/GIP/glucagon receptor agonists available. But starting at the wrong dose — or jumping up too fast — is the #1 beginner mistake. Here's the complete titration roadmap.
9mRunning Retatrutide and wondering what to add? This guide breaks down how MOTS-C, SS-31, AOD-9604, and SLU-PP-332 layer onto a GLP-1 protocol — and why they're not redundant.
10mMost fat-loss compounds either suppress appetite or boost energy expenditure. 5-Amino-1MQ does something different — it blocks the enzyme that burns through your NAD+ and keeps fat cells from ever getting broken down. Here's why it stacks so well with Reta and MOTS-C.
9mHitting a plateau on Retatrutide is common and usually temporary. Here's the science behind GLP-1 stalls and the practical steps to break through them.
8mAOD-9604 is a synthetic fragment of human growth hormone designed specifically to stimulate fat breakdown without the glucose or IGF-1 side effects of full HGH. Here's how it works and who it's for.
9mTesamorelin is an FDA-approved GHRH analog with clinical trials proving 15–20% visceral fat reduction. Here's the full science, dosing guide, and what the latest research reveals about its longevity applications.
11mA 2026 meta-analysis comparing retatrutide to GLP-1 (Ozempic/Wegovy) and tirzepatide shows retatrutide delivers 28% superior fat loss. Here's the science behind why the triple-agonist approach is reshaping weight loss and body recomposition.
10mThe biggest risk with GLP-1 weight loss drugs isn't the fat loss — it's the muscle you lose with it. Strategic peptide stacking can tip the balance toward true body recomposition.
9mEverything you need to know before your first retatrutide injection — reconstitution math, dose calculations, injection technique, and what to expect if you have prior GLP-1 sensitivity.
10mRetatrutide is not just a stronger tirzepatide. It's a fundamentally different molecule with three receptor targets instead of two. Here's how each mechanism contributes to rapid fat loss, metabolic optimization, and muscle preservation.
10mRapid fat loss typically means muscle loss. But retatrutide's triple action—including glucagon receptor activation—preserves more lean mass than tirzepatide or GLP-1-only compounds. Here's the science.
18mFrom BPC-157 and GLP-1 agonists at the top to overhyped flops at the bottom — here's every major peptide ranked for 2026 across fat loss, skin, longevity, and recovery.
9mExplore why Ipamorelin is considered the gentlest yet effective growth hormone releasing peptide available.
8mDiscover how AOD-9604 targets fat metabolism specifically, offering a focused approach to body composition.
Also available at /blog for legacy links.